SNIM Trademark

Trademark Overview


On Thursday, December 21, 2023, a trademark application was filed for SNIM with the United States Patent and Trademark Office. The USPTO has given the SNIM trademark a serial number of 79395760. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, April 4, 2025. This trademark is owned by Ethris GmbH. The SNIM trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases more specifically, lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections, namely viral, bacterial, fungal or parasitic infections and pathogen-caused diseases, namely respiratory system diseases, in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases; Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and panc...

Preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances, namely, chemical reagents used in the manufacture of biological preparations and preparation comprising nucleic acids and nanocarriers and/or nanoparticles; biological preparations regarding use in industry and science; nucleic acids and organic chemicals for use in industry and science, other than for medical or veterinary purposes; industrial organic chemicals; organic chemicals used in the industry; detergents for use in manufacture of nanocarriers or nanoparticles and its formulations, formulations comprising nucleuic acids, detergents for use in manufacturing processes in the industry; salts for industrial purposes; chemicals and organic compositions being organic chemicals for use in the manufacture of food and beverages; Aqueous chemical compositions, namely, compositions comprising nucleic acids and nanocarriers or nanoparticles and its formulations; Triglycerides being chemical a...

Preparation and dispensing of medications; human fertility treatment; human fertility treatment services; Vaccination services, namely, administering vaccines to patients, preparation of vaccine and vaccination material, testing of vaccines; regenerative medicine services; dispensing of pharmaceuticals; Health care services, namely, respiratory system, antiviral, bone, heart, and tendon therapy services; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems, particularly, respiratory system diseases, in the nature of lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen infections being viral, bacterial, fungal or parasitic infections and pathogen-caused diseases being respiratory system diseases, in the nature of viral induced asthma; medical treatment services, namely, medical treatment of diseases and conditions affecting various bod...

Research on the subject of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; Biotechnology testing, namely, product testing for others, namely, nucleic acids testing, nanocarrier testing, aerosol testing, vaccine testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; animal genetics resear...
snim

General Information


Serial Number79395760
Word MarkSNIM
Filing DateThursday, December 21, 2023
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, April 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases more specifically, lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections, namely viral, bacterial, fungal or parasitic infections and pathogen-caused diseases, namely respiratory system diseases, in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases; Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections, muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic infections and pathogen-caused diseases in particular respiratory system diseases in particular viral induced asthma, congenital diseases, autoimmune diseases; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections, muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, including:: in the nature of skin infections, in particular bacterial, viral, fungal, or parasitic infections; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, in the nature of inflammatory skin diseases, particularly psoriasis, eczema, dermatitis, and rosacea; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, in the nature of acne and acne-related disorders, particularly comedonal acne, inflammatory acne, and nodulocystic acne; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, in the nature of pigmentation disorders, in particular melasma, vitiligo, and post-inflammatory hyperpigmentation, skin cancers, particularly melanoma, basal cell carcinoma, and squamous cell carcinoma; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, in the nature of hair and scalp conditions, in particular alopecia, dandruff, and seborrheic dermatitis; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, in the nature of nail disorders, particularly onychomycosis, nail psoriasis, and paronychia, wound care and healing products, in particular those for diabetic ulcers, pressure ulcers, and surgical wounds; cosmetic dermatology treatments being medicated skin care preparations, particularly anti-aging treatments, skin rejuvenation, and scar reduction; medicated skin care preparations for sun protection and photodamage, in particular sunscreens, photoprotective agents, and treatments for sunburn, treatments for skin allergies, in particular urticaria, contact dermatitis, and drug-induced skin reactions, skin hydration and barrier repair products, particularly emollients, moisturizers, and barrier creams, products for rare dermatological diseases, in particular epidermolysis bullosa, ichthyosis, and pemphigus vulgaris; products medicated skin care preparations for cellulite reduction, stretch marks, and skin tightening; palliative care for skin conditions, in particular pain management, itch relief, and symptomatic care for chronic skin diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies and lung autoimmune diseases, pathogen in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases and viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; dermatological pharmaceutical products being dermatological preparations; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases, and viral induced asthma, congenital diseases in particular primary ciliary dyskinesia, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders, bone fracture; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; antidiabetic pharmaceuticals; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases, in particular viral induced asthma, congenital diseases in particular primary ciliary dyskinesia, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections, muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, in the nature of cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Tissue-regenerative pharmaceutical preparations for the treatment of conditions affecting the respiratory system, in particular lung tissue repair, airway regeneration, and recovery from lung fibrosis, skin and mucosal tissues, particularly wound healing, burns, ulcers, surgical wounds, diabetic foot ulcers, pressure sores, oral mucositis, and mucosal lesions, bone regeneration, in particular in cases of fractures, osteoporosis, bone grafts, and bone defects, dental applications, particularly regeneration of teeth, periodontal tissues, dental pulp, and treatment of alveolar bone loss, circulatory system conditions, in particular heart tissue repair after myocardial infarction, ischemic injury, heart failure, arterial and venous regeneration, treatment of peripheral artery disease, and vascular grafts; Tissue-regenerative pharmaceutical preparations for regeneration of soft tissues, particularly tendons, ligaments and cartilage; treatment of nerve injuries, particularly peripheral nerve regeneration and spinal cord injury repair, treatment of muscle injuries, in particular muscular dystrophies, myopathies, and muscle atrophy; Tissue-regenerative pharmaceutical preparations applications in organ repair and regeneration, particularly liver regeneration, kidney regeneration, and intestinal tissue repair, ophthalmic regeneration, in particular corneal repair, retinal regeneration, and treatment of ocular surface diseases, regenerative treatments for reproductive tissues, in particular uterine or ovarian tissue regeneration, and treatment of rare diseases involving tissue degeneration or defects, in particular epidermolysis bullosa, osteogenesis imperfecta, and amyotrophic lateral sclerosis (ALS); cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; anaesthetic preparations for inhalation being inhalant anesthetics; pharmaceutical preparations for inhalers for the treatment of respiratory diseases and disorders; Sanitary preparations and articles, namely, disinfectants and antiseptics for skin and surfaces, antimicrobial hand sanitizers, antimicrobial wipes, wound cleansing solutions and sprays, barrier creams and lotions for skin protection, LNP-enhanced wound dressings, sterile bandages and gauze infused with regenerative agents, sanitizing sprays for medical devices and equipment, nasal sprays for decontamination, treatment and pathogen prevention, oral hygiene products in particular mouth rinses and gels, eye drops for sterile cleansing and infection prevention, personal hygiene products like feminine hygiene sprays, LNP-enhanced protective masks and filters, air purifying sprays and filters, pre-surgical skin preparation solutions, LNP-based decontaminating agents for burns and cuts, sanitizing gels and creams for dermatitis and skin conditions, sanitizing agents for public health emergencies, foot and nail fungal treatment sprays, surface sanitizers for household and industrial use; air deodorising and air purifying preparations; Hygienic preparations and articles, namely, aerosol sprays for respiratory lung disease management, in particular antiviral and antibacterial aerosol sprays for upper and lower respiratory tract protection, mucolytic sprays to break down mucus and improve airflow, LNP-enhanced nasal mRNA expression sprays, aerosolized vaccines for respiratory pathogens, in particular influenza or COVID-19,inhalable sprays containing nanocarriers, aerosol sprays for chronic obstructive pulmonary disease (COPD) management, particularly treatments for bronchitis and emphysema, immune-boosting sprays for respiratory health maintenance, sprays delivering regenerative agents for lung tissue repair and fibrosis treatment, inhalable sprays with LNPs targeting primary ciliary dyskinesia, cystic fibrosis or other genetic lung disorders; pulmonary delivery systems for managing asthma, particularly rescue and maintenance therapies, aerosolized sprays with nanoparticle-based antibiotics or antivirals for treating bacterial or viral lung infections, LNP-based sprays for preventing and managing acute respiratory distress syndrome (ARDS), inhalable sprays for reducing pulmonary inflammation and oxidative stress, sprays for localized drug delivery to specific areas of the respiratory tract, prophylactic sprays for occupational lung disease prevention, inhalable agents for managing smoke inhalation injury or pollution-related respiratory damage, and LNP-based sprays for targeted delivery of gene therapies or RNA-based treatments for lung diseases; Dental preparations for regeneration of teeth, periodontal tissues, dental pulp, and treatment of alveolar bone loss; dental articles, namely, materials for tooth restoration, dental cements, dental filling materials, bone fillers consisting of living materials and bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations adapted for medical purposes; Pest control preparations and articles, namely, insect repellent preparations, insecticides, acaricides; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds, namely, pharmaceutical preparations for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; autoantigens, namely, pharmaceutical preparations for the treatment and prevention of human autoimmune diseases and cancer; vaccines; vaccine preparations; vaccine adjuvants; Veterinary vaccines for animals, in particular bovine, caprine, sheep, horse, poultry, cat and dog; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; Antiviral drugs being antivirals for treating influenza; vaccines for human use; Fat emulsions, namely, formulations comprising nucleic acids and/or nanocarriers in particular lipid nanoparticles for medical infusions; Medical preparations, namely medical preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations, aerosols formulations, spray formulations; Medicinal healthcare preparations namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations, aerosols formulations, spray formulations; Medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; Medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; Medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases, viral induced asthma, congenital diseases; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of bone fracture, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Medicinal preparations and substances, namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; Medicine for diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; Medicine for diseases and conditions affecting various body systems in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections, muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders; Medicine for diseases and conditions affecting various body systems in the nature of ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Medicine for diseases and conditions affecting various body systems in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; Medicine for diseases and conditions affecting various body systems in the nature of hematologic diseases, in particular anemia, hemophilia, and clotting disorders; Medicine for diseases and conditions affecting various body systems in the nature of cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; Serotherapeutic medicines for passive immunity, modulating immune responses, convalescent plasma therapies, treating autoimmune diseases, inflammatory conditions, cancer, viral infections, and preventing or treating allergic reactions; antiallergic medicines; Medicines for animals, namely, medicine for diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune disease, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Medicines for animals, namely, medicine for diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; Medicines for animals, namely, medicine for diseases and conditions affecting various body systems, in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes; Medicines for animals, namely, medicine for diseases and conditions affecting various body systems, in the nature of lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration and ocular infections, ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; nucleic acid sequences for medical and veterinary purposes; Acids for pharmaceutical purposes, namely nucleic acids, recombinant nucleic acids, fatty acid esters, phospholipids, Ionizable Lipids, cholesterol derivative acids; adjuvants for medical purposes; cellular function activating agents for medical purposes; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders, bone fracture; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration; palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; chemical preparations for veterinary purposes for the treatment of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections in particular viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases in particular respiratory system diseases and viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections, muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, in particular lymphedema and lymphatic infections, psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; Chemical preparations for veterinary purposes for the treatment of diseases and conditions affecting various body systems in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, in particular anemia, hemophilia, and clotting disorders, cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds being pharmaceutical preparations for treating cancer; pharmaceutical preparations for activating cellular function; vaccines for cattle; vaccines for horses; veterinary vaccines for bovine animals; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention of allergies; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the prevention of diseases caused by bacteria; pharmaceutical preparations for treating arthritis; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated creams for treating dermatological conditions; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems, in the nature of respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections being viral, bacterial, fungal or parasitic infections and pathogen-caused diseases being respiratory system diseases, in particular viral induced asthma; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of congenital diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of autoimmune diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of immune system diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of circulatory system diseases, in particular cardiovascular diseases, blood disorders, and vascular diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of urinary system diseases, in particular kidney diseases, bladder disorders, and urinary tract infections; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of tendon diseases, bone diseases, in particular osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of endocrine system diseases, in particular diabetes, thyroid disorders, and adrenal gland disorders; metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of lymphatic system diseases, in particular lymphedema and lymphatic infections; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of ocular diseases, in particular glaucoma, macular degeneration, and ocular infections; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, in particular anemia, hemophilia, and clotting disorders; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration; pharmaceutical preparations and substances for the treatment of diseases and conditions affecting various body systems in the nature of palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses bronchodilating preparations, organotherapeutic preparations being derived from bones or tendons, palliative care conditions, in particular pain management and supportive care for chronic or terminal illnesses
Goods and ServicesPreservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances, namely, chemical reagents used in the manufacture of biological preparations and preparation comprising nucleic acids and nanocarriers and/or nanoparticles; biological preparations regarding use in industry and science; nucleic acids and organic chemicals for use in industry and science, other than for medical or veterinary purposes; industrial organic chemicals; organic chemicals used in the industry; detergents for use in manufacture of nanocarriers or nanoparticles and its formulations, formulations comprising nucleuic acids, detergents for use in manufacturing processes in the industry; salts for industrial purposes; chemicals and organic compositions being organic chemicals for use in the manufacture of food and beverages; Aqueous chemical compositions, namely, compositions comprising nucleic acids and nanocarriers or nanoparticles and its formulations; Triglycerides being chemical additives for use in the manufacture of medicines, medical formulations and medicines comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; triglycerides being chemical additives for use in the manufacture of food; nucleic recombinant acids for scientific purposes; nucleic acids, other than for medical or veterinary purposes; nucleic acids for scientific purposes; pyrimidine; Lipids for use in manufacture of medicines or pharmaceutical formulations, namely, medicines comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; Hydrosoluble polymers for use in medicines and/or pharmaceutical formulations; Polymer dispersions for use in medicines and/or pharmaceutical formulations; biodegradable polymer compositions used in the manufacture of commercial and industrial goods, namely, medicines and/or pharmaceutical formulations; Hydrogel polymer coating for use in medicines and/or pharmaceutical formulations; Cationic polymers for use in medicines and/or pharmaceutical formulations; polymer solutions for use in medicines and/or pharmaceutical formulations; Aqueous polymer dispersions for use in medicines and/or pharmaceutical formulations; Fatty acid esters for use in medicines and/or pharmaceutical formulations
Goods and ServicesPreparation and dispensing of medications; human fertility treatment; human fertility treatment services; Vaccination services, namely, administering vaccines to patients, preparation of vaccine and vaccination material, testing of vaccines; regenerative medicine services; dispensing of pharmaceuticals; Health care services, namely, respiratory system, antiviral, bone, heart, and tendon therapy services; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems, particularly, respiratory system diseases, in the nature of lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen infections being viral, bacterial, fungal or parasitic infections and pathogen-caused diseases being respiratory system diseases, in the nature of viral induced asthma; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems, particularly, congenital diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of autoimmune diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of immune system diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of nervous system diseases, particularly neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of circulatory system diseases, in the nature of cardiovascular diseases, blood disorders, and vascular diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of digestive system diseases, particularly gastrointestinal diseases, liver diseases, and pancreatic diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of urinary system diseases, in the nature of kidney diseases, bladder disorders, and urinary tract infections; reproductive system diseases, particularly infertility, hormonal disorders, and reproductive tract infections; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of muscular diseases, particularly muscular dystrophies, myopathies, and inflammatory muscle diseases; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of tendon diseases, bone diseases, in the nature of osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of skin diseases, particularly dermatological conditions, inflammatory skin diseases, and skin infections; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of endocrine system diseases, in the nature of diabetes, thyroid disorders, and adrenal gland disorders; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of metabolic diseases, particularly genetic metabolic disorders and acquired metabolic syndromes; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of lymphatic system diseases, in the nature of lymphedema and lymphatic infections; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of psychiatric and mental health conditions, particularly mood disorders, anxiety disorders, and psychotic disorders; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of ocular diseases, in the nature of glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, particularly rhinitis, sinusitis, otitis, and throat infections; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of hematologic diseases, in the nature of anemia, hemophilia, and clotting disorders; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of cosmetic conditions, particularly treatments for aesthetic improvement, skin rejuvenation, and hair restoration; medical treatment services, namely, medical treatment of diseases and conditions affecting various body systems in the nature of palliative care conditions, in the nature of pain management and supportive care for chronic or terminal illnesses
Goods and ServicesResearch on the subject of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; Biotechnology testing, namely, product testing for others, namely, nucleic acids testing, nanocarrier testing, aerosol testing, vaccine testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; animal genetics research; scientific research relating to molecular sciences; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research in the field of genetics; scientific research relating to genetics

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 16, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 16, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 16, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEthris GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, May 16, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 17, 2024APPLICATION FILING RECEIPT MAILED
Thursday, August 8, 2024REFUSAL PROCESSED BY MPU
Thursday, August 8, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 22, 2024ASSIGNED TO EXAMINER
Tuesday, July 23, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, August 25, 2024REFUSAL PROCESSED BY IB
Friday, February 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 4, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 4, 2025EXAMINER'S AMENDMENT ENTERED
Friday, April 4, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, April 4, 2025EXAMINERS AMENDMENT E-MAILED
Friday, April 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER